Myocardial Infarction News and Research

RSS

AI model for detecting ocular disease using retinal images

Researchers present RETFound, a self-supervised learning masked autoencoder-based foundation model for retinal images.

18 Sep 2023

Machine learning shows promise for coronary artery disease risk assessment

Researchers investigated the performance of a machine learning-based model in evaluating radiomic features to diagnose coronary artery disease.

13 Sep 2023

Estimating life expectancy based on the age of type 2 diabetes diagnosis

The association between the age of diabetes diagnosis and life expectancy.

13 Sep 2023

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

September 7th, 2023, the University of Birmingham and Acticor Biotech announce the full regulatory approval of LIBERATE clinical study.

9 Sep 2023

Obesity in early pregnancy increases long-term risk of venous thromboembolism

Investigated the association between obesity in early pregnancy and long-term post-pregnancy risk of venous thromboembolism.

7 Sep 2023

High dietary intake of added sugars could increase the risk of coronary heart disease

The associations between individual dietary sugar types and the risk of coronary heart disease.

6 Sep 2023

Heart protective effect of red blood cells is enhanced by nitrate-rich vegetable diet

Red blood cells exposed to oxygen deficiency protect against myocardial infarction, according to a new KI study published in the Journal of Clinical Investigations.

1 Sep 2023

Study suggests sepsis as a considerable burden to public health

A research team at Lund University in Sweden has found that more than four percent of all hospital admissions in southern Sweden are associated with sepsis.

31 Aug 2023

Is drinking water hardness associated with cardiovascular disease mortality?

Total drinking water hardness can protect against cardiovascular disease mortality.

30 Aug 2023

Easy-to-implement strategy more than doubles new diagnoses of cardiovascular disease

Active screening of patients with type 2 diabetes or chronic obstructive pulmonary disease (COPD) more than doubles new diagnoses of cardiovascular disease compared with usual care, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

ARAMIS trial finds no benefit of anakinra in acute myocarditis

The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischemic events in acute coronary syndrome (ACS) patients at high risk for both types of events.

29 Aug 2023

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces cardiac events compared to placebo in patients at risk of renal injury undergoing coronary angiography for acute coronary syndrome, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

A recent study in the Journal of Biomedical Science examines the critical role of ACE2, an enzyme involved in blood volume and electrolyte balance, in chronic diseases like cardiovascular conditions, diabetes, and COVID-19. The research suggests that ACE2 could serve as both a disease severity biomarker and a therapeutic target.

28 Aug 2023

Trial addresses the optimal timing for complete revascularization of patients with STEMI and multivessel disease

Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel PCI for reducing death and ischaemic events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock who are scheduled for early revascularization, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Myocardial Infarction News and Research

AI model for detecting ocular disease using retinal images

Machine learning shows promise for coronary artery disease risk assessment

Estimating life expectancy based on the age of type 2 diabetes diagnosis

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

Obesity in early pregnancy increases long-term risk of venous thromboembolism

High dietary intake of added sugars could increase the risk of coronary heart disease

Heart protective effect of red blood cells is enhanced by nitrate-rich vegetable diet

Study suggests sepsis as a considerable burden to public health

Is drinking water hardness associated with cardiovascular disease mortality?

Easy-to-implement strategy more than doubles new diagnoses of cardiovascular disease

ARAMIS trial finds no benefit of anakinra in acute myocarditis

Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

Trial addresses the optimal timing for complete revascularization of patients with STEMI and multivessel disease

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News